Biblio Discovery — Demo Discovery Service

97 hasil untuk "Elliott Perry M"

Menampilkan 1–20 · 0,40 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?

    Protonotarios, Alexandros; Elliott, Perry M

    Eur Cardiol · 2020 · Inggris · PubMed Central

    Arrhythmogenic cardiomyopathy (AC) is a clinical entity that has evolved conceptually over the past 30 years. Advances in cardiac imaging and the introduction of genetics into everyday practice have revealed that AC comprises multiple phenotypes that are dependent on genetic or acquired factors. In…

  2. Artikel Jurnal Teks lengkap

    Genetic aspects and investigation of sudden death in young people

    Lambiase, Pier D; Elliott, Perry M

    Clin Med (Lond) · 2008 · Inggris · PubMed Central

  3. Artikel Jurnal Teks lengkap

    Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice

    Lopes, Luis R; Ho, Carolyn Y; Elliott, Perry M

    Eur Heart J · 2024 · Inggris · PubMed Central

    Pathogenic variation in genes encoding proteins of the cardiac sarcomere is responsible for 30%–40% of cases of hypertrophic cardiomyopathy. The main clinical utility of genetic testing is to provide diagnostic confirmation and facilitation of family screening. It also assists in the detection of…

  4. Artikel Jurnal Teks lengkap

    Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy

    Braunwald, Eugene; Saberi, Sara; Abraham, Theodore P dkk.

    Eur Heart J · 2023 · Inggris · PubMed Central

    Mavacamten is a first-in-class, targeted, cardiac-specific myosin inhibitor approved by the US Food and Drug Administration for the treatment of adults with symptomatic New York Heart Association Classes II and III obstructive hypertrophic cardiomyopathy (oHCM). Mavacamten was developed to target…

  5. Artikel Jurnal Teks lengkap

    Is QT Dispersion Associated with Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy?

    Yi, Gang; Poloniecki, Jan; Dickie, Shaughan dkk.

    Ann Noninvasive Electrocardiol · 2006 · Inggris · PubMed Central

    QT dispersion is significantly greater in patients with hypertrophic cardiomyopathy (HCM) than that in healthy subjects. Few data exist regarding the prognostic value of QT dispersion in HCM. In this study, we retrospectively investigated the association between QT dispersion and sudden cardiac…

  6. Artikel Jurnal Teks lengkap

    Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion

    Honarbakhsh, Shohreh; Protonotarios, Alexander; Monkhouse, Christopher dkk.

    Europace · 2023 · Inggris · PubMed Central

    AIMS: Arrhythmogenic right ventricular cardiomyopathy (ARVC) patients develop ventricular arrhythmias (VAs) responsive to anti-tachycardia pacing (ATP). However, VA episodes have not been characterized in accordance with the device therapy, and with the emergence of the subcutaneous implantable…

  7. Artikel Jurnal Teks lengkap

    Heart Rate Recovery in Patients With Hypertrophic Cardiomyopathy

    Patel, Vimal; Critoph, Christopher H.; Finlay, Malcolm C. dkk.

    Am J Cardiol · 2014 · Inggris · PubMed Central

    Recovery in heart rate (HR) after exercise is a measure of autonomic function and a prognostic indicator in cardiovascular disease. The aim of this study was to characterize heart rate recovery (HRR) and to determine its relation to cardiac function and morphology in patients with hypertrophic…

  8. Artikel Jurnal Teks lengkap

    Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block

    Cannie, Douglas; Patel, Kush; Protonotarios, Alexandros dkk.

    Open Heart · 2024 · Inggris · PubMed Central

    OBJECTIVE: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an infiltrative cardiac disorder caused by deposition of wild type or mutated transthyretin. As ATTR-CM is associated with conduction disease, we sought to determine its prevalence in patients with idiopathic high-degree atrioventricular…

  9. Artikel Jurnal Teks lengkap

    Prevalence of Hypertrophic Cardiomyopathy in the UK Biobank Population

    Lopes, Luis R.; Aung, Nay; van Duijvenboden, Stefan dkk.

    JAMA Cardiol · 2021 · Inggris · PubMed Central

    This cohort study examines the prevalence of hypertrophic cardiomyopathy in the UK Biobank population.

  10. Artikel Jurnal Teks lengkap

    Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making

    Norrish, Gabrielle; Protonotarios, Alexandros; Stec, Maria dkk.

    Europace · 2023 · Inggris · PubMed Central

    AIMS: The validated HCM Risk-Kids model provides accurate individualized estimates of sudden cardiac death risk in children with hypertrophic cardiomyopathy (HCM). A second validated model, PRIMaCY, also provides individualized estimates of risk, but its performance and clinical impact has not been…

  11. Artikel Jurnal Teks lengkap

    Myosin inhibitors for treatment of hypertrophic cardiomyopathy

    Quill, Samuel; Amin, Ahmad S; Asselbergs, Folkert W dkk.

    Cochrane Database Syst Rev · 2025 · Inggris · PubMed Central

    This is a protocol for a Cochrane Review (intervention). The objectives are as follows: PRIMARY OBJECTIVE: To assess the effects of myosin inhibitors compared to usual care or placebo on exercise capacity, need for septal reduction therapy, and all‐cause mortality in people with hypertrophic…

  12. Artikel Jurnal Teks lengkap

    Isolated aortic root dilation in homocystinuria

    Lorenzini, Massimiliano; Guha, Nishan; Davison, James E. dkk.

    J Inherit Metab Dis · 2017 · Inggris · PubMed Central

    BACKGROUND: Vascular complications in homocystinuria have been known for many years, but there have been no reports to date on involvement of the ascending aorta. METHODS: We conducted a cross-sectional study of patients with homocystinuria, known to a single metabolic centre, and evaluated in 2016…